Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big Dialyzer

This study has been completed.
Sponsor:
Collaborators:
Advanced Dialysis Center of Potomac
Advanced Dialysis Center of Easton
Information provided by:
Gambro Renal Products, Inc.
ClinicalTrials.gov Identifier:
NCT00659724
First received: April 14, 2008
Last updated: May 27, 2011
Last verified: May 2011

April 14, 2008
May 27, 2011
March 2008
May 2008   (final data collection date for primary outcome measure)
  • Ease of Use: Priming Blood Side [ Time Frame: Priming at each treatment ] [ Designated as safety issue: No ]

    For every study treatment/dialyzer, the nursing staff rated the ease of priming blood side as follows:

    Very Easy:Air is easily removed without knocking or clamping procedures. Acceptable:Knocking and/or clamping required for efficient air removal. Difficult:Knocking and/or clamping and additional volume of saline or extended recirculation needed to remove air.

    Very Difficult:Air could not be removed.

  • Ease of Use: Priming Dialysate Side [ Time Frame: Priming at each treatment ] [ Designated as safety issue: No ]

    For every study treatment/dialyzer, the nursing staff rated the ease of priming dialysate side as follows:

    Dialysate Side at 500 ml Priming Volume (check one):

    Perfect: No air visible. Acceptable: Some air visible, but considered insignificant. Not Acceptable: Additional actions needed to sufficiently remove air.

  • Dialyzer Assessment: Fiber Condition [ Time Frame: Each treatment: assessment of the condition of the dialyzer fibers after rinse-back ] [ Designated as safety issue: No ]

    For every study treatment/dialyzer, the nursing staff rated the condition of the dialyzer fibers after rinse-back as follows:

    Very Good:All fibers appear white. Good:Few fibers (less than 10) appear PINK / RED. (check one) Poor:Several fibers (more than 10) appear PINK / RED. (check one) Very Poor:Most fibers (more than 75%) appear PINK / RED. (check one)

  • Dialyzer Assessment: Arterial Header Condition [ Time Frame: Each treatment: assessment of the condition of the arterial header after rinse-back ] [ Designated as safety issue: No ]

    For every study treatment/dialyzer, the nursing staff rated the condition of the arterial header after rinse-back as follows:

    Very Good:Surface as clean as expected. Good:Distinct red ring appears at the dialyzer wall. Poor:Significant appearance of clots, randomly distributed on the surface. Very Poor:Completely red and/or covered with clots.

  • Dialyzer Assessment: Venous Header Condition [ Time Frame: Each treatment: the assessment of the condition of the venous header after rinse-back ] [ Designated as safety issue: No ]

    For every study treatment/dialyzer, the nursing staff rated the condition of the venous header after rinse-back as follows:

    Very Good:Surface as clean as expected. Good:Distinct red ring appears at the dialyzer wall. Poor:Significant appearance of clots, randomly distributed on the surface. Very Poor:Completely red and/or covered with clots.

For every study treatment/dialyzer, the nursing staff will complete a questionnaire regarding the ease of priming and rinse-back, and visually assess residual blood and clots in the dialyzer after rinse-back. [ Time Frame: Priming and rinse-back of each dialyzer ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT00659724 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big Dialyzer
The Gambro Polyflux HD-C4 Big Ease Of Use And Thrombogenicity Study

The purpose of this study is to collect information on the ease of use and thrombogenicity of the Polyflux HD-C4 Big and Fresenius Optiflux 180NR or 200NR dialyzers under conditions of routine clinical use for hemodialysis.

This ease of use study involves the use of FDA 510(k) cleared hemodialyzers and will have no impact on the patient's routine dialysis therapy. This study is aimed at obtaining feedback from the nursing and technical staff regarding the use and thrombogenicity of the Polyflux HD-C4 Big, and Fresenius Optiflux 180NR or 200NR dialyzers. The dialysis nursing staff will complete ease of use and thrombogenicity assessments following routine dialysis therapy. Any adverse events will be tracked for the study patients.

Observational
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Assessment of dialyzer ease of use and thrombogenicity assessments following routine dialysis therapy of 33 adult patients (18 years of age or older)

Chronic Kidney Failure
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
33
May 2008
May 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Hemodialysis patients 18 years of age or older

Exclusion Criteria:

  • n/a
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00659724
Gambro 1462
No
Jeffrey Shideman, Ph.D., Director US Clinical Affairs, Gambro Renal Products, Inc.
Gambro Renal Products, Inc.
  • Advanced Dialysis Center of Potomac
  • Advanced Dialysis Center of Easton
Not Provided
Gambro Renal Products, Inc.
May 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP